Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to ...

Ingelheim: Boehringer Ingelheim and Eko Health have entered a strategic collaboration agreement to improve heart murmur ...

Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...

By combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...